EGFR and lung cancer: This was demonstrated in a number of studies, whereby we see the transfer of EGFR from lung cancer cells to endothelial cells, dendritic cells, macrophages and monocytes, activating pro-tumourigenic pathways in these low EGFR expressing recipient cells.